BJDX Stock Summary and Trading Ideas (Bluejay Diagnostics | NASDAQ:BJDX)

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

Bluejay Diagnostics trades on the NASDAQ stock market under the symbol BJDX.

As of January 26, 2026, BJDX stock price declined to $0.79 with 40,126 million shares trading.

BJDX has a beta of -0.17, meaning it tends to be less sensitive to market movements. BJDX has a correlation of 0.00 to the broad based SPY ETF.

BJDX has a market cap of $1.43 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, BJDX traded as high as $7,040.00 and as low as $.63.

BJDX has underperformed the market in the last year with a return of -80.2%, while the SPY ETF gained +14.8%. In the last 3 month period, BJDX fell short of the market, returning -67.5%, while SPY returned +3.4%. However, in the most recent 2 weeks BJDX has outperformed the stock market by returning +19.4%, while SPY returned -0.2%.

BJDX support price is $.75 and resistance is $.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BJDX shares will trade within this expected range on the day.